118 related articles for article (PubMed ID: 15878836)
1. TB subunit vaccines--putting the pieces together.
Andersen P; Doherty TM
Microbes Infect; 2005 May; 7(5-6):911-21. PubMed ID: 15878836
[TBL] [Abstract][Full Text] [Related]
2. Prospects for a novel vaccine against tuberculosis.
Dietrich J; Weldingh K; Andersen P
Vet Microbiol; 2006 Feb; 112(2-4):163-9. PubMed ID: 16325357
[TBL] [Abstract][Full Text] [Related]
3. Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis.
West NP; Thomson SA; Triccas JA; Medveczky CJ; Ramshaw IA; Britton WJ
Vaccine; 2011 Oct; 29(44):7759-65. PubMed ID: 21846485
[TBL] [Abstract][Full Text] [Related]
4. A PE_PGRS33 protein of Mycobacterium tuberculosis: an ideal target for future tuberculosis vaccine design.
Gastelum-Aviña P; Velazquez C; Espitia C; Lares-Villa F; Garibay-Escobar A
Expert Rev Vaccines; 2015 May; 14(5):699-711. PubMed ID: 25693607
[TBL] [Abstract][Full Text] [Related]
5. Differential proteomics approach to identify putative protective antigens of Mycobacterium tuberculosis presented during early stages of macrophage infection and their evaluation as DNA vaccines.
Sharma S; Rajmani RS; Kumar A; Bhaskar A; Singh A; Manivel V; Tyagi AK; Rao KV
Indian J Exp Biol; 2015 Jul; 53(7):429-39. PubMed ID: 26245027
[TBL] [Abstract][Full Text] [Related]
6. [From genetics to genomics in the rational design of new Mycobacterium tuberculosis vaccines].
Bocanegra-García V; Valencia-Delgadillo J; Cruz-Pulido W; Cantú-Ramírez R; Rivera-Sánchez G; Palma-Nicolás JP
Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):609-14. PubMed ID: 21684635
[TBL] [Abstract][Full Text] [Related]
7. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
[TBL] [Abstract][Full Text] [Related]
8. Vaccine potential of Mycobacterium tuberculosis-specific genomic regions: in vitro studies in humans.
Mustafa AS
Expert Rev Vaccines; 2009 Oct; 8(10):1309-12. PubMed ID: 19803751
[No Abstract] [Full Text] [Related]
9. Cloning, expression, and immunogenicity of novel fusion protein of Mycobacterium tuberculosis based on ESAT-6 and truncated C-terminal fragment of HSP70.
Tebianian M; Hoseini AZ; Ebrahimi SM; Memarnejadian A; Mokarram AR; Mahdavi M; Sohrabi N; Taghizadeh M
Biologicals; 2011 May; 39(3):143-8. PubMed ID: 21388826
[TBL] [Abstract][Full Text] [Related]
10. New tuberculosis vaccines.
Martín Montañés C; Gicquel B
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
[TBL] [Abstract][Full Text] [Related]
12. The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs.
Commandeur S; van den Eeden SJ; Dijkman K; Clark SO; van Meijgaarden KE; Wilson L; Franken KL; Williams A; Christensen D; Ottenhoff TH; Geluk A
Vaccine; 2014 Jun; 32(29):3580-8. PubMed ID: 24837764
[TBL] [Abstract][Full Text] [Related]
13. Development of vaccines against tuberculosis.
Tyagi AK; Nangpal P; Satchidanandam V
Tuberculosis (Edinb); 2011 Sep; 91(5):469-78. PubMed ID: 21334259
[TBL] [Abstract][Full Text] [Related]
14. Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines.
Romano M; Aryan E; Korf H; Bruffaerts N; Franken CL; Ottenhoff TH; Huygen K
Microbes Infect; 2012 Jan; 14(1):86-95. PubMed ID: 21920450
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis subunit vaccines: from basic science to clinical testing.
Doherty TM; Dietrich J; Billeskov R
Expert Opin Biol Ther; 2007 Oct; 7(10):1539-49. PubMed ID: 17916046
[TBL] [Abstract][Full Text] [Related]
16. Selecting the components for a safe and efficient tuberculosis subunit vaccine--recent progress and post-genomic insights.
Okkels LM; Doherty TM; Andersen P
Curr Pharm Biotechnol; 2003 Feb; 4(1):69-83. PubMed ID: 12570683
[TBL] [Abstract][Full Text] [Related]
17. New multistage TB vaccine shown to produce stronger, longer-lasting response against Mycobacterium tuberculosis.
Immunotherapy; 2011 Mar; 3(3):309. PubMed ID: 21395372
[No Abstract] [Full Text] [Related]
18. Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens.
Derrick SC; Yabe IM; Yang A; Kolibab K; Hollingsworth B; Kurtz SL; Morris S
Vaccine; 2013 Sep; 31(41):4641-6. PubMed ID: 23906890
[TBL] [Abstract][Full Text] [Related]
19. Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX.
Niu H; Hu L; Li Q; Da Z; Wang B; Tang K; Xin Q; Yu H; Zhang Y; Wang Y; Ma X; Zhu B
Vaccine; 2011 Nov; 29(51):9451-8. PubMed ID: 22024175
[TBL] [Abstract][Full Text] [Related]
20. Cutinase-like protein-6 of Mycobacterium tuberculosis is recognised in tuberculosis patients and protects mice against pulmonary infection as a single and fusion protein vaccine.
Shanahan ER; Pinto R; Triccas JA; Britton WJ; West NP
Vaccine; 2010 Feb; 28(5):1341-6. PubMed ID: 19941992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
